\-\ Texto\\:\\ \ \(0\)\
\-\ this\\ patient\\ was\\ found\\ to\\ have\\ c\\.\\ difficile\\ toxin\\ in\\ her\\ stool\\.\ \(0\)\
\-\ this\\ patient\\ was\\ managed\\ surgically\\ with\\ colectomy\\.\ \(0\)\
\-\ \\â\\€\\¢\\ dilated\\ transverse\\ colon\\ \\>\\ 5\\.5\\ cm\ \(0\)\
\-\ toxic\\ megacolon\\ \\(complication\\ of\\ ulcerative\\ colitis\\)\ \(0\)\
\-\ \\â\\€\\¢\\ ileus\ \(0\)\
\-\ \\â\\€\\¢\\ pseudomembranous\\ colitis\ \(0\)\
\-\ \\â\\€\\¢\\ toxic\\ megacolon\\ \\(complication\\ of\\ ulcerative\\ colitis\\)\ \(0\)\
\-\ \\â\\€\\¢\\ clostridium\\ difficile\\ colitis\ \(0\)\
\-\ \\â\\€\\¢\\ crohn\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ cytomegalovirus\\ infection\ \(1\)\
\-\ \\â\\€\\¢\\ drug\\-induced\\ colitis\ \(1\)\
\-\ \\â\\€\\¢\\ ischemic\\ colitis\ \(1\)\
\-\ 57\\ y\\.o\\.\\ woman\\ admitted\\ for\\ two\\ weeks\\ history\\ of\\ abdominal\\ pain\\ and\\ eight\\ dark\\,\\ loose\\ stools\\ per\\ day\\.\\ patient\\ has\\ an\\ eight\\-year\\ history\\ of\\ ulcerative\\ colitis\\.\\ patient\\ was\\ initially\\ managed\\ medically\\ for\\ an\\ ulcerative\\ colitis\\ exacerbation\\.\\ initial\\ acute\\ abdominal\\ series\\ obtained\\ on\\ hospital\\ day\\ 2\\ \\(films\\ 1\\-3\\)\\.\\ the\\ second\\ acute\\ abdominal\\ series\\ \\(films\\ 4\\-6\\)\\ was\\ obtained\\ following\\ greatly\\ increased\\ abdominal\\ pain\\,\\ fever\\,\\ and\\ abdominal\\ distention\\.\ \(0\)\
\-\ toxic\\ megacolon\\ is\\ a\\ well\\-known\\ complication\\ of\\ chronic\\ ulcerative\\ colitis\\,\\ but\\ it\\ can\\ also\\ present\\ in\\ association\\ with\\ crohn\\&\\#34\\;s\\ disease\\,\\ psuedomembranous\\ colitis\\,\\ amebic\\ colitis\\,\\ and\\ other\\ infectious\\ causes\\.\\ marked\\ dilation\\ of\\ the\\ colon\\ is\\ obvious\\ in\\ these\\ patients\\.\\ the\\ wall\\ of\\ the\\ colon\\ becomes\\ extremely\\ thin\\,\\ friable\\,\\ and\\ susceptible\\ to\\ spontaneous\\ perforation\\.\\ distention\\ is\\ usually\\ best\\ noted\\ in\\ the\\ transverse\\ colon\\ of\\ a\\ supine\\ patient\\.\\ toxic\\ megacolon\\ is\\ defined\\ as\\ distention\\ of\\ the\\ colon\\ \\(\\>5\\.5cm\\)\\.\\ pseudopolypoid\\ projections\\ are\\ frequently\\ noted\\.\\ spontaneous\\ perforation\\ of\\ the\\ colon\\ is\\ the\\ major\\ complication\\.\\ because\\ of\\ the\\ risk\\ of\\ perforation\\ barium\\ enema\\ is\\ absolutely\\ contraindicated\\.\\ \ \(0\)\
\-\ this\\ patient\\ was\\ also\\ found\\ to\\ have\\ c\\.\\ difficile\\ toxin\\ in\\ her\\ stool\\.\\ positive\\ c\\.\\ difficile\\ toxin\\ the\\ stool\\ with\\ associated\\ acute\\ abdominal\\ symptoms\\ is\\ diagnostic\\ for\\ psuedomembranous\\ colitis\\.\\ \\ the\\ combination\\ of\\ chronic\\ ulcerative\\ colitis\\ and\\ psuedomembranous\\ colitis\\ raises\\ interesting\\ questions\\ as\\ to\\ the\\ true\\ etiology\\ of\\ her\\ development\\ of\\ toxic\\ megacolon\\.\ \(0\)\
\-\ this\\ patient\\ was\\ managed\\ surgically\\ with\\ colectomy\\.\ \(0\)\
\-\ http\\:\\/\\/www\\.ncbi\\.nlm\\.nih\\.gov\\.lrc1\\.usuhs\\.edu\\/pmc\\/articles\\/pmc3134807\\/\\?tool\\=pubmed\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ colitis\\:\\ 0\\.5562404687466252\ \(0\)\
\-\ megacolon\\:\\ 0\\.2771329941069543\ \(0\)\
\-\ ulcerative\\:\\ 0\\.2710621731730182\ \(0\)\
\-\ difficile\\:\\ 0\\.2116581664309674\ \(0\)\
\-\ toxic\\:\\ 0\\.20518627329753036\ \(0\)\
\-\ psuedomembranous\\:\\ 0\\.18418232148141064\ \(0\)\
\-\ colon\\:\\ 0\\.18354291186912083\ \(0\)\
\-\ toxin\\:\\ 0\\.15672981957466203\ \(0\)\
\-\ complication\\:\\ 0\\.14595712412505873\ \(0\)\
\-\ abdominal\\:\\ 0\\.13183914626177357\ \(0\)\
\-\ stool\\:\\ 0\\.12019279060867814\ \(0\)\
\-\ of\\:\\ 0\\.11793328777272856\ \(0\)\
\-\ managed\\:\\ 0\\.1179325806683928\ \(0\)\
\-\ distention\\:\\ 0\\.11703334015631557\ \(0\)\
\-\ perforation\\:\\ 0\\.11377629616853706\ \(0\)\
\-\ colectomy\\:\\ 0\\.09678794527031322\ \(0\)\
\-\ the\\:\\ 0\\.09619824803874723\ \(0\)\
\-\ patient\\:\\ 0\\.09147011408007961\ \(0\)\
\-\ eight\\:\\ 0\\.08989218109209178\ \(0\)\
\-\ was\\:\\ 0\\.08400990903827374\ \(0\)\
\-\ crohn\\:\\ 0\\.07821923662896521\ \(0\)\
\-\ is\\:\\ 0\\.07701684144593023\ \(0\)\
\-\ her\\:\\ 0\\.0752986148124726\ \(0\)\
\-\ surgically\\:\\ 0\\.0745694378974601\ \(0\)\
\-\ series\\:\\ 0\\.07367950145383903\ \(0\)\
\-\ spontaneous\\:\\ 0\\.06991766167460689\ \(0\)\
\-\ acute\\:\\ 0\\.06520065692798832\ \(0\)\
\-\ pseudopolypoid\\:\\ 0\\.06424979289622251\ \(0\)\
\-\ absolutely\\:\\ 0\\.06424979289622251\ \(0\)\
\-\ films\\:\\ 0\\.06363127259924299\ \(0\)\
\-\ transverse\\:\\ 0\\.061909718051397916\ \(0\)\
\-\ obtained\\:\\ 0\\.056835829808228155\ \(0\)\
\-\ clostridium\\:\\ 0\\.05542659882139086\ \(0\)\
\-\ this\\:\\ 0\\.05522046404164677\ \(0\)\
\-\ amebic\\:\\ 0\\.054486138876582824\ \(0\)\
\-\ friable\\:\\ 0\\.054486138876582824\ \(0\)\
\-\ cytomegalovirus\\:\\ 0\\.052243273191554015\ \(0\)\
\-\ found\\:\\ 0\\.05199110124518327\ \(0\)\
\-\ day\\:\\ 0\\.05118254491485195\ \(0\)\
\-\ pseudomembranous\\:\\ 0\\.050544771811571014\ \(0\)\
\-\ susceptible\\:\\ 0\\.050544771811571014\ \(0\)\
\-\ questions\\:\\ 0\\.050544771811571014\ \(0\)\
\-\ in\\:\\ 0\\.049972131049149326\ \(0\)\
\-\ contraindicated\\:\\ 0\\.04917733340599149\ \(0\)\
\-\ raises\\:\\ 0\\.04877476740507822\ \(0\)\
\-\ greatly\\:\\ 0\\.04839397263515661\ \(0\)\
\-\ chronic\\:\\ 0\\.04769437047585106\ \(0\)\
\-\ projections\\:\\ 0\\.047048372968369744\ \(0\)\
\-\ medically\\:\\ 0\\.046748626131010676\ \(0\)\
\-\ stools\\:\\ 0\\.04646111732908103\ \(0\)\
\-\ exacerbation\\:\\ 0\\.0440913475329102\ \(0\)\
\-\ ileus\\:\\ 0\\.04369996975931805\ \(0\)\
\-\ noted\\:\\ 0\\.042602262472113496\ \(0\)\
\-\ interesting\\:\\ 0\\.04247961917191432\ \(0\)\
\-\ loose\\:\\ 0\\.041866799121190824\ \(0\)\
\-\ and\\:\\ 0\\.04150914878384508\ \(0\)\
\-\ extremely\\:\\ 0\\.041168903120856165\ \(0\)\
\-\ enema\\:\\ 0\\.040533970061017235\ \(0\)\
\-\ supine\\:\\ 0\\.04029520185234985\ \(0\)\
\-\ to\\:\\ 0\\.0401754483127084\ \(0\)\
\-\ have\\:\\ 0\\.04013999562547162\ \(0\)\
\-\ dark\\:\\ 0\\.03941367938635179\ \(0\)\
\-\ true\\:\\ 0\\.03901111338543853\ \(0\)\
\-\ becomes\\:\\ 0\\.038447373586419045\ \(0\)\
\-\ 57\\:\\ 0\\.037925432056179015\ \(0\)\
\-\ also\\:\\ 0\\.03779505593506287\ \(0\)\
\-\ obvious\\:\\ 0\\.03736169225715954\ \(0\)\
\-\ combination\\:\\ 0\\.03728471894873005\ \(0\)\
\-\ for\\:\\ 0\\.036530897180290796\ \(0\)\
\-\ association\\:\\ 0\\.036155427649686225\ \(0\)\
\-\ barium\\:\\ 0\\.035774632879764616\ \(0\)\
\-\ ischemic\\:\\ 0\\.035531747168718895\ \(0\)\
\-\ dilation\\:\\ 0\\.03535492647706567\ \(0\)\
\-\ major\\:\\ 0\\.03512586604060037\ \(0\)\
\-\ 34\\:\\ 0\\.03501407023904365\ \(0\)\
\-\ disease\\:\\ 0\\.03372871692908524\ \(0\)\
\-\ per\\:\\ 0\\.03334335188371823\ \(0\)\
\-\ development\\:\\ 0\\.033213323803743644\ \(0\)\
\-\ frequently\\:\\ 0\\.0330856528585198\ \(0\)\
\-\ admitted\\:\\ 0\\.03291894714401231\ \(0\)\
\-\ etiology\\:\\ 0\\.032364718470837384\ \(0\)\
\-\ infectious\\:\\ 0\\.03232675079065389\ \(0\)\
\-\ best\\:\\ 0\\.03232675079065389\ \(0\)\
\-\ as\\:\\ 0\\.032280060489206105\ \(0\)\
\-\ initially\\:\\ 0\\.03150562592066826\ \(0\)\
\-\ with\\:\\ 0\\.03146766743575222\ \(0\)\
\-\ thin\\:\\ 0\\.03127360063986638\ \(0\)\
\-\ an\\:\\ 0\\.03072615457470046\ \(0\)\
\-\ history\\:\\ 0\\.030698935290414023\ \(0\)\
\-\ diagnostic\\:\\ 0\\.030620140040036874\ \(0\)\
\-\ marked\\:\\ 0\\.030386326448258696\ \(0\)\
\-\ causes\\:\\ 0\\.030357638067991344\ \(0\)\
\-\ second\\:\\ 0\\.030077003827483594\ \(0\)\
\-\ http\\:\\ 0\\.02970200337102541\ \(0\)\
\-\ hospital\\:\\ 0\\.02967596641857145\ \(0\)\
\-\ dilated\\:\\ 0\\.02877459808726282\ \(0\)\
\-\ pain\\:\\ 0\\.0287527337471547\ \(0\)\
\-\ risk\\:\\ 0\\.0287063294982921\ \(0\)\
\-\ defined\\:\\ 0\\.028661181987171127\ \(0\)\
\-\ because\\:\\ 0\\.028078428097871127\ \(0\)\
\-\ fever\\:\\ 0\\.027239683128519324\ \(0\)\
\-\ initial\\:\\ 0\\.02695143880493296\ \(0\)\
\-\ positive\\:\\ 0\\.02647376509872932\ \(0\)\
\-\ usually\\:\\ 0\\.02529213196397134\ \(0\)\
\-\ wall\\:\\ 0\\.02443938159128395\ \(0\)\
\-\ infection\\:\\ 0\\.02426848615899614\ \(0\)\
\-\ following\\:\\ 0\\.024101639394318572\ \(0\)\
\-\ weeks\\:\\ 0\\.024078123554049344\ \(0\)\
\-\ two\\:\\ 0\\.02385855406624974\ \(0\)\
\-\ cm\\:\\ 0\\.023073396996756652\ \(0\)\
\-\ these\\:\\ 0\\.02268724756405332\ \(0\)\
\-\ patients\\:\\ 0\\.022601064451197694\ \(0\)\
\-\ symptoms\\:\\ 0\\.021981902222992462\ \(0\)\
\-\ increased\\:\\ 0\\.021725142770876532\ \(0\)\
\-\ associated\\:\\ 0\\.021175640386205213\ \(0\)\
\-\ can\\:\\ 0\\.021082968159455196\ \(0\)\
\-\ woman\\:\\ 0\\.020923669241598983\ \(0\)\
\-\ other\\:\\ 0\\.020863919253401197\ \(0\)\
\-\ present\\:\\ 0\\.02061548937076277\ \(0\)\
\-\ it\\:\\ 0\\.020565412051285592\ \(0\)\
\-\ but\\:\\ 0\\.019866978069236003\ \(0\)\
\-\ has\\:\\ 0\\.018351118363322844\ \(0\)\
\-\ are\\:\\ 0\\.015244875248220371\ \(0\)\
\-\ on\\:\\ 0\\.012133770328454092\ \(0\)\
